Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest
A phase 2/3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 501 participants.
Also called NCT03640949
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2/3
- Enrolled
- 501 participants
- Registry
-
NCT03640949 -
2017-004773-13
-
- Other papers using this trial's data
- Effect of Vasopressin and Methylprednisolone vs Placebo on Return of Spontaneous Circulation in Patients With In-Hospital Cardiac Arrest: A Randomized Clinical Trial
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Denmark
- Registry status
- Completed
Technical summary
Registry record NCT03640949. Randomized; quadruple masking; primary purpose treatment. Start 2018-09-17 (actual); primary completion 2021-01-21 (actual). Results posted on 2022-01-11.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Vasopressin and Methylprednisolone for In-Hospital Cardiac Arrest
- Acronym
- VAM-IHCA
- Condition
- Heart Arrest
- Intervention (Drug)
- Vasopressin, Arginine
- Intervention (Drug)
- Methylprednisolone
- Intervention (Drug)
- NaCl
- Lead sponsor
- Lars Wiuff Andersen
- Collaborator
- University of Aarhus
Record details
- Record id
cardio:ct-nct03640949- Content hash
ec3fa495a4eca6facfcbcd5ab30de4ad012e092ea75aa4d0499c77108423166f